# FDA Inspection 1051248 - Xellia (Taizhou) Pharmaceuticals - April 06, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/xellia-taizhou-pharmaceuticals/efd3b62d-c1cc-45b9-a741-0d826895654f
Source feed: FDA_Inspections

> FDA Inspection 1051248 for Xellia (Taizhou) Pharmaceuticals on April 06, 2018. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1051248
- Company Name: Xellia (Taizhou) Pharmaceuticals
- Inspection Date: 2018-04-06
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1051248 - 2018-04-06](https://www.globalkeysolutions.net/records/fda_inspections/xellia-taizhou-pharmaceuticals/5a9c58cd-d3fd-4067-83da-870e1114afab)
- [FDA Inspection 923425 - 2015-03-26](https://www.globalkeysolutions.net/records/fda_inspections/xellia-taizhou-pharmaceuticals/deb1198d-cfd1-49df-848d-75cea67343e3)
- [FDA Inspection 801705 - 2012-09-20](https://www.globalkeysolutions.net/records/fda_inspections/xellia-taizhou-pharmaceuticals/826f5c9a-bc50-4cf8-912d-46d9ac9dde82)
- [FDA Inspection 570393 - 2009-02-27](https://www.globalkeysolutions.net/records/fda_inspections/xellia-taizhou-pharmaceuticals/1dcf0c6d-43c3-4b7f-9758-ec2553abed78)

Company: https://www.globalkeysolutions.net/companies/xellia-taizhou-pharmaceuticals/d0debe75-9c46-480f-a6b6-4695ad2bb771

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c